Prosecution Insights
Last updated: April 19, 2026

Mitsubishi Tanabe Pharma Corporation

13 pending office actions

Portfolio Summary

13
Total Pending OAs
8
Final Rejections
5
Non-Final OAs

Pending Office Actions

App #TitleExaminerArt UnitStatusFiled
18839045 INFORMATION PROCESSING DEVICE, INFORMATION PROCESSING SYSTEM, INFORMATION PROCESSING METHOD AND PROGRAM KANAAN, LIZA TONY 3683 Non-Final OA Aug 16, 2024
18500142 METHOD FOR TREATING AMYOTROPHIC LATERAL SCLEROSIS AND METHOD FOR SUPPRESSING PROGRESS OF AMYOTROPHIC LATERAL SCLEROSIS SAEED, KAMAL A 1626 Non-Final OA Nov 02, 2023
18549653 INFORMATION PROCESSING DEVICE, INFORMATION PROCESSING SYSTEM, INFORMATION PROCESSING METHOD, AND PROGRAM PORTER, RACHEL L 3684 Final Rejection Sep 08, 2023
18001917 MODULATION OF DRUG-DRUG INTERACTIONS OF VADADUSTAT ANDERSON, JAMES D 1629 Non-Final OA Dec 15, 2022
18009128 PROPHYLACTIC OR THERAPEUTIC AGENT FOR PHOTODERMATOSIS CORNET, JEAN P 1628 Final Rejection Dec 08, 2022
17998463 COMPOUND, METHOD AND PHARMACEUTICAL COMPOSITION FOR REGULATING EXPRESSION OF ATAXIN 3 POLIAKOVA-GEORGAN, EKATERINA 1637 Final Rejection Nov 10, 2022
17792673 AGENT FOR PREVENTION OR TREATMENT OF DIABETIC AUTONOMIC NEUROPATHY MOSELEY II, NELSON B 1642 Final Rejection Jul 13, 2022
17792574 PROPHYLACTIC OR THERAPEUTIC AGENT FOR DEMENTIA WANG, CHANG YU 1675 Final Rejection Jul 13, 2022
17757955 AGENT FOR PREVENTING OR TREATING ACUTE-PHASE NEUROMYELITIS OPTICA WANG, CHANG YU 1675 Final Rejection Jun 24, 2022
17772856 THERAPEUTIC METHODS USING VADADUSTAT SZNAIDMAN, MARCOS L 1628 Final Rejection Apr 28, 2022
17513383 PHARMACEUTICAL AGENT FOR TREATING AMYOTROPHIC LATERAL SCLEROSIS OR SUPPRESSING DISEASE PROGRESS THEREOF MCMILLIAN, KARA RENITA 1623 Final Rejection Oct 28, 2021
17276106 HUMAN ANTI-IL-33 MONOCLONAL ANTIBODY-CONTAINING PHARMACEUTICAL COMPOSITION DONOGHUE, BRITTNEY ERIN 1675 Non-Final OA Mar 12, 2021
17258741 PREVENTION OR TREATMENT METHOD FOR PERIPHERAL NEUROPATHY OR PAIN ACCOMPANYING DISEASE IN WHICH PERIPHERAL NEUROPATHY OR ASTROCYTE DISORDER IS RECOGNIZED PETRASH, HILARY ANN 1644 Non-Final OA Jan 07, 2021

Managing Mitsubishi Tanabe Pharma Corporation's Patent Portfolio?

IP Author helps IP teams respond to office actions faster with AI-generated responses, examiner analytics, and prosecution intelligence.

Start Free Trial

Sign in with your work email

Enter your email to receive a magic link. No password needed.

Personal email addresses (Gmail, Yahoo, etc.) are not accepted.

Free tier: 3 strategy analyses per month